U.S. Specialty Stores Stock News

Haemonetics Corporation recently received U.S. Food and Drug Administration 510(k) clearance for its NexSys PCS Plasma Collection System with Persona PLUS technology, supported by a large multicenter trial of over 30,000 plasma donations showing improved average plasma volume per donation while maintaining safety. This next-generation, donor-tailored collection technology could enhance plasma center efficiency and reinforce Haemonetics’ position in high-value plasma collection...

In recent weeks, Pagaya Technologies reported softer-than-expected first-quarter guidance but reiterated that it is seeing no operational slippage or credit stress, even as broader market volatility weighed on sentiment. Analysts have reaffirmed positive views on the company, arguing that its AI-driven underwriting platform and measured growth outlook remain intact despite short-term market noise. With analysts highlighting management’s reassurance about stable operations, we’ll now...

Perfect (PERF) has just wrapped up FY 2025 with Q4 revenue of US$18.1 million and basic EPS of US$0.01, set against trailing twelve month revenue of US$69.2 million and EPS of US$0.05. Over recent quarters the company has seen revenue move from US$15.9 million in Q4 FY 2024 to US$18.1 million in Q4 FY 2025, while quarterly EPS has ranged between about US$0.002 and US$0.025 across FY 2025. This gives investors a clearer view of how growth and profitability are interacting. With a trailing net...

In February 2026, Jumia Technologies AG reported its fourth-quarter and full-year 2025 results, with sales rising to US$61.4 million for the quarter and US$188.93 million for the year, while net losses narrowed to US$10.31 million and US$61.55 million respectively versus the prior year. The company also filed its 2025 Annual Report on Form 20-F with the SEC, offering investors a detailed view of how its pan-African marketplace, logistics network, and payment infrastructure are evolving as it...

Webster Financial (WBS) has been drawing fresh attention after recent share price moves, with the stock last closing at $72.42. That brings its reported past 3 months total return to about 21%. See our latest analysis for Webster Financial. The recent 30 day share price return of 13.0% and 90 day share price return of 21.9% sit alongside a 1 year total shareholder return of 34.3%. This points to momentum that has built over a longer horizon rather than just a short term bounce. If Webster...

Integer Holdings (ITGR) FY 2025 earnings snapshot Integer Holdings (ITGR) has wrapped up FY 2025 with fourth quarter revenue of $472.1 million and basic EPS of $1.39, rounding out a trailing twelve month EPS of $2.96 on $1.9 billion of revenue and net income of $102.8 million from ongoing operations. The company has seen quarterly revenue range from $437.4 million in Q1 2025 to $476.5 million in Q2 2025. Quarterly EPS moved from a Q1 loss of $0.66 to positive readings of $1.06, $1.13 and...

A senior Kinder Morgan (NYSE:KMI) executive recently sold company shares, drawing investor attention to insider activity. The company announced its ninth consecutive annual dividend increase, extending a long-running pattern of higher payouts. Kinder Morgan highlighted continued investment in large pipeline expansion projects alongside its dividend focus. Kinder Morgan, trading at $32.69, is in the spotlight as investors weigh insider selling against a multiyear record of dividend growth...

Valuation snapshot and recent performance Old Second Bancorp (OSBC) has been drawing attention after recent trading left the shares with mixed short term returns and longer term gains. This has prompted investors to reassess how its current price lines up with fundamentals. The stock shows a 1 day return of 1.18%, a 7 day return reflecting a 4.99% decline, roughly flat performance over the past month, and a 4.05% return over the past 3 months, set against a 10.70% total return over the past...

Targa Resources (NYSE:TRGP) announced a major build out of natural gas processing plants in the Permian Basin. The company is adding a new large scale NGL fractionator, Train 13, at its Mont Belvieu complex. Targa outlined additional growth projects, including carbon capture initiatives and AI driven technology upgrades across its system. The expansion is described as aimed at meeting rising energy demand tied to data centers and broader market needs. Targa Resources, a large midstream...

MediaAlpha FY 2025 Earnings Snapshot MediaAlpha (MAX) has wrapped up FY 2025 with fourth quarter revenue of US$291.2 million and basic EPS of US$0.56, alongside trailing twelve month revenue of about US$1.1 billion and EPS of US$0.46 that sit against earnings growth of 54.1% over the past year. Over the last few quarters, the company has seen revenue range from US$251.6 million to US$306.5 million per quarter. EPS swung from a loss of US$0.33 in Q2 2025 to a profit of US$0.26 in Q3 and...

Arvinas (ARVN) just wrapped up FY 2025 with Q4 revenue of US$9.5 million and a basic EPS loss of US$1.04, alongside a Q4 net loss of US$67.4 million. This capped a year in which quarterly revenue swung from US$188.8 million in Q1 to US$9.5 million in Q4 and EPS moved from a Q1 profit of US$1.14 to successive quarterly losses. Over the trailing twelve months to Q4 2025, the company booked total revenue of US$262.6 million and a net loss of US$80.8 million, so the latest print keeps the focus...

Sotera Health (SHC) has put a full year of results on the table, with Q4 FY 2025 revenue of US$303.4 million and basic EPS of US$0.12, rounding out trailing 12 month revenue of about US$1.2 billion and EPS of US$0.27 that follows earnings growth of 75.8% over the past year. Over recent quarters the company has seen revenue move from US$254.5 million in Q1 FY 2025 to US$311.3 million in Q3 and US$303.4 million in Q4. Quarterly basic EPS has ranged from a loss of US$0.05 in Q1 to US$0.17 in Q3...

Expeditors International of Washington (EXPD) just wrapped up FY 2025 with fourth quarter revenue of US$2.9 billion and basic EPS of US$1.50, alongside net income of US$200.7 million. Together, these results set the tone for how the full year will be judged. Over recent quarters, the company has seen revenue range from US$2.7 billion to US$3.0 billion, while quarterly EPS moved between roughly US$1.35 and US$1.69. This gives investors a clearer view of how the top and bottom lines have...

Arm Holdings recently reported record fiscal Q3 revenue growth driven by higher royalty and licensing demand tied to AI-focused chip designs, while Nvidia completed the sale of its roughly US$140 million minority stake, ending its equity ownership but keeping their technology relationship intact. At the same time, Malaysia is pushing an agreement to use Arm’s intellectual property to build a local chip-design ecosystem, underlining Arm’s growing global importance in AI and semiconductor...

Nutanix (NTNX) is drawing attention after a period of weaker share performance, including a 43.4% negative total return over the past year. This is prompting investors to reassess its cloud software business and recent financial profile. See our latest analysis for Nutanix. While Nutanix’s recent 7 day share price return of 7.55% and 30 day share price return of 11.56% add to a 25.18% year to date share price decline, the 34.02% three year total shareholder return suggests earlier momentum...

Establishment Labs Holdings (NasdaqCM:ESTA) just wrapped FY 2025 with Q4 revenue of US$64.6 million and a basic EPS loss of US$0.09, alongside trailing twelve month revenue of US$211.1 million and a TTM basic EPS loss of US$1.72. The company has seen quarterly revenue move from US$40.2 million in Q3 2024 to US$64.6 million in Q4 2025, while quarterly basic EPS losses shifted from US$1.19 in Q4 2024 to US$0.09 in Q4 2025, setting up an earnings story where stronger top line figures are still...

Cogent Biosciences (NasdaqGS:COGT) has advanced its lead therapy bezuclastinib into a Phase 3 trial for systemic mastocytosis. The company has also filed a significant shelf registration that could be used to raise capital in the future. These updates highlight progress in Cogent Biosciences' clinical pipeline alongside preparations for potential funding needs. Cogent Biosciences enters this news cycle with its shares at $39.18 and very large 1 year returns, reflecting strong recent...

Upbound Group (UPBD) has wrapped up FY 2025 with Q4 revenue of US$1.2 billion and basic EPS of US$0.35, while trailing twelve month figures show revenue of US$4.7 billion and EPS of US$1.30 against a current share price around US$21.62. Over the past six quarters, the company has seen revenue move from US$1.08 billion in Q4 2024 to US$1.20 billion in Q4 2025, with quarterly EPS ranging between US$0.23 and US$0.57 along the way. This gives investors a clear view of how the top line and per...

Capital One Financial (NYSE:COF) has announced plans to acquire Discover Financial Services and has entered a definitive agreement to acquire Brex. The transactions aim to expand Capital One's payments network and broaden its customer reach across consumer and business segments. Both deals are drawing regulatory attention and come alongside an investor investigation and concerns about credit conditions. For you as an investor, these moves come at a time when NYSE:COF shares trade around...

ASML Holding stock performance and business snapshot ASML Holding (NasdaqGS:ASML) has drawn investor attention recently, with the share price at $1,497.80 and total returns over the past year, 3 years, and 5 years all in positive territory. The company reports annual revenue of €32.67b and net income of €9.61b, with both revenue and earnings showing positive annual growth. ASML focuses on lithography, metrology, and inspection systems used in advanced semiconductor manufacturing. Its...

Tarsus Pharmaceuticals (TARS) closed FY 2025 with fourth quarter revenue of US$151.7 million and a basic EPS loss of US$0.20, while net income excluding extra items came in at a loss of US$8.4 million. The company has seen quarterly revenue move from US$48.1 million and a basic EPS loss of US$0.61 in Q3 2024 to US$151.7 million and a loss of US$0.20 per share in Q4 2025. Trailing twelve month EPS stands at a loss of US$1.59 on revenue of US$451.4 million, outlining a picture where higher...

Great Lakes Dredge & Dock (GLDD) capped FY 2025 with Q4 revenue of US$256.5 million and basic EPS of US$0.19, rounding out a trailing twelve month picture that includes total revenue of US$888.3 million and EPS of US$1.10. Over the past few quarters, the company has seen revenue move from US$191.2 million in Q3 2024 to US$202.8 million in Q4 2024, then to US$242.9 million in Q1 2025 and US$195.2 million in Q3 2025, with quarterly EPS ranging from US$0.13 to US$0.50 over the same stretch. This...

Repligen (RGEN) closed out FY 2025 with Q4 revenue of US$197.9 million and basic EPS of US$0.24, alongside net income of US$13.3 million, giving investors a clear snapshot of its latest quarterly performance. Over recent periods, the company has seen revenue move from US$167.5 million in Q4 2024 to US$197.9 million in Q4 2025, while basic EPS shifted from a loss of US$0.60 to a profit of US$0.24. This set up a year where trailing twelve month EPS reached US$0.87 on revenue of US$738.3 million...

Portillo's (PTLO) has wrapped up FY 2025 with fourth quarter revenue of US$185.7 million and basic EPS of US$0.08, alongside net income of US$6.1 million. This update gives investors an opportunity to reassess how the full year stacks up against its recent history. The company has seen quarterly revenue move from US$176.4 million in Q1 2025 to a range between US$181.4 million and US$188.5 million through the year, while EPS shifted between US$0.02 and US$0.13, giving a mixed read on profit...